LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Apr 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-04-12

Reporting Person: Pecora Andrew L (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-12	Common stock, $0.001 par value	A	8478	$0.32	Acquired	2013982	Direct

Footnotes

F1: Effective April 11, 2012, the Issuer and the Reporting Person entered into an amendment (the "Amendment") to the Reporting Person's employment agreement dated September 23, 2010, as amended. Pursuant to the terms of the Amendment, the Reporting Person agreed to receive, at his option on a quarterly basis, the amount of his net salary commencing with the pay period ending April 7, 2012, through the issuance to him by the Issuer of shares of the Issuer's common stock at the then-market price at the time of issuance for the applicable payroll date, under and subject to the terms and conditions of the Issuer's 2009 Equity Compensation Plan.